Evidence map›Paper›PMID 36213716›Full record

ArticleIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine2022

Role of Biomarkers and Its Trend to Predict the Outcome of COVID-19 Patients: A Retrospective Study.

Amarja Ashok Havaldar, Veronica Lobo, Ea Chinny Sushmitha, Kumar M Vinay, John Michael Raj, Tinku Thomas

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amarja Ashok HavaldarDepartment of Critical Care Medicine, St John's Medical College and Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0002-8763-3585
Veronica LoboDepartment of Critical Care Medicine, St John's Medical College and Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0002-8366-9847
Ea Chinny SushmithaDepartment of Critical Care Medicine, St John's Medical College and Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0001-5141-9010
Kumar M VinayDepartment of Critical Care Medicine, St John's Medical College and Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0002-3577-2196
John Michael RajDepartment of Biostatistics, St John's Medical College and Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0002-1526-7432
Tinku ThomasDepartment of Biostatistics, St John's Medical College and Hospital, Bengaluru, Karnataka, India.ORCID https://orcid.org/0000-0002-1786-6076
St.John's Medical College Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Biomarkers have been extensively studied and used in the diagnosis and management of various diseases. The trend of biomarkers helps in prognosticating and managing critically ill patients. In resource-limited settings, the availability and feasibility of using these biomarkers are challenging.Our study aimed to see the trend of biomarkers and their effect on intensive care unit (ICU) mortality in coronavirus disease-2019 (COVID-19) patients. Materials and methods: A retrospective observational study was done from 1 April 2020 to 30 September 2020. The primary objective was to evaluate the trend of biomarkers in patients with COVID-19 pneumonia and their effect on ICU mortality. The secondary objectives were the duration of mechanical ventilation and length of ICU stay. Results: A total of 380 patients were included. The mean age was 54.9 (SD = 11.1) and 67% were males. The mean age, acute physiology and chronic health evaluation II (APACHE II) score was 29.54 (5.8). Among the biomarkers, total count (TC), ferritin, and procalcitonin (PCT) were higher in non-survivors than in survivors in bivariate analysis. The final multivariable logistic regression model showed age, APACHE II score, length of ICU stay, neutrophil:lymphocyte (NL) ratio, and ferritin as covariates. Among these variables, ferritin was the only biomarker [odds ratio (OR): 1.80, 95% confidence interval (CI) 1.17-2.77] with the APACHE II score (OR: 1.15, 95% CI 1.01-1.30) found to be significant. Conclusion: Ferritin was the only significant biomarker with higher values in non-survivors than in survivors. The trend of biomarkers was not found to be useful in predicting outcome of the patients. How to cite this article: Havaldar AA, Lobo V, Sushmitha EAC, Kumar VM, Raj JM, Thomas T. Role of Biomarkers and Its Trend to Predict the Outcome of COVID-19 Patients: A Retrospective Study. Indian J Crit Care Med 2022;26(9):1031-1035.

Indexed as

BiomarkersCoronavirus disease-2019C-reactive proteinD-dimerFerritinneutrophil:lymphocyte ratio

Identifiers

PMID36213716
PMCPMC9492755
OpenAlexW3158676020

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.